EAACI 2021

10/07/2021 - 12/07/2021

Krakow, Poland

Watch the content from our past Annual Congresses – re-discover talks that impressed you, or refresh your knowledge with lectures you did not have the chance to listen to before.

Visit Event

Filter

What are you looking for?

Category
- Aerobiology and pollution
- Allergen immunotherapy
- AllergoOncology
- Allergy asthma and a sport
- Allergy diagnosis
- Allied health and primary care
- Anaphylaxis
- Asthma
- Basic immunology
- Biologicals
- Comparative veterinary allergology
- COVID19
- Dermatology
- Drug allergy
- ENT
- Environmental allergy and climate change
- Eosinophilic esophagitis
- Epidemiology
- Epithelial cell biology
- Food allergy
- Food Allergy and Anaphylaxis
- Genomics and proteomics
- Immune deficiencies and autoimmunity
- Immunomodulation and nutrition
- Infections
- Insect venom hypersensitivities
- Mastocytosis and mast cells
- Microbiome
- Occupational allergy
- Ocular allergy
- OMIC Technologies in Allergy Research
- Pediatrics
- Prevention
- Systems medicine
- T2 Diseases
Type
- Abstract Book
- Poster
- Presentation
Year
- 2013
- 2014
- 2015
- 2016
- 2017
- 2019
- 2020
- 2021
- 2022
- 2023
Keywords
- nasal polyps…)
- sinusitis
- vaccines and mechanisms
- “omics” and systems biology
- “omics” and systems biology
- (reverse) zoonosis
- AAMP
- Abdominal pain
- ABPA
- ACE2
- Acoustic rhinometry
- acute respiratory tract infection
- Adherence
- Adjuvant
- Adjuvants
- adolescent
- Adolescents
- adolesent and young adult (AYA)
- Adrenaline
- Adrenaline auto-injector
- adults
- adverse drug reaction
- advocacy
- aerd
- aerobiology
- aerosolization
- Air pollutant
- Air pollution
- Airborne enzyme
- airways
- AIT
- Algorithm
- allegen immunotherapy (AIT)
- allergen
- allergen exposure challenge
- allergen immunotherapy
- allergen immunotherapy (AIT)
- Allergen labelling
- Allergen sequence database
- Allergen-free foods
- allergen-immuntherapie
- allergens and epitopes
- Allergens and epitopes
- allergic asthma
- Allergic conjunctivitis (AC)
- Allergic contact dermatitis
- allergic disease
- allergic diseases
- allergic rhinitis
- Allergic rhinitis (AR)
- allergicdiseases
- allergicrhinitis
- allergie
- allergoid-mannan conjugates
- AllergoOncology WG
- allergy
- Allergy diagnosis
- allergy diagnosis
- allergy epidemiology
- allergy hypersensititvy
- allergy management
- Allergy risk
- allergy test
- allergy therapeutics
- allergy treament
- allergy treatment
- Allergy treatment
- allergy/hypersensitivity
- alpha-gal allergy
- ALR
- Alternaria
- altitude
- Anaphylaxis
- Angioedema
- angiotensin-convertingenzyme2
- angiotensin-convertingenzymeII
- Animal models
- Anosmi
- anti-epileptic drugs
- antibiotics
- Antibodies
- antibody
- antibody-dependentenhancement
- antibodydynamics
- Antiepileptic drugs hypersensitivity
- antigen presenting cells
- Antolimab
- Api m 10
- APOE
- ARPC1B
- Artificial intelligence
- Asthma
- asthma control
- asthma exacerbations
- Asthma treatment
- Asthma treatment
- asymptomatic
- atopic dermatitis
- Atopic dermatitis
- Atopic dermatitis (AD)
- Atopic deseases
- Atopic eczema
- Atopic eosinophilic asthma
- atopy
- Autoallergen
- Autoimmunity
- Autoinflammation
- Avapritinib
- Azelastine fluticasone
- B cells
- B regulatory cells
- bacterial lysate
- bacterial lysates
- bacterial mucosal immunotherapy
- Barrier
- Basic and Clinical Immunology Section
- Basic immunology
- Basic mechanisms
- basic mechanisms
- Basophil
- Basophil activation test
- basophil activation test (BAT)
- Bathing
- Bcells
- Beijing
- Benralizumab
- berotralstat
- Bet v 1
- beta-lactam
- beta-lactam allergy
- Big data
- bigdata
- Bioinformatics
- Biological detergents
- biologicals
- Biologics
- biologika
- biomarker
- Biomarkers
- biosafety
- Biotin
- Birch
- Birch pollen
- blood
- blood eosinophil
- BNT162b2
- Bovine milk
- Breast milk
- Breastfeeding
- Breg cells
- bronchial allergen challenge
- bronchial asthma
- bronchial thermoplasty
- bronchiectasis
- Bronchiolitis
- Bronchoconstriction
- BTK
- c-kit
- cabbage
- cancer
- cannabis allergy
- case study
- causality
- Cellular test
- Challenge tests
- challenge tests
- chemotherapy
- child
- Childhood allergies
- childhood asthma
- childhoodvaccination
- children
- china
- chlorhexidine
- chlorination by-products
- Chronic respiratory
- Chronic rhinosinusitis
- Chronic rhinosinusitis with nasal polyposis (CRSwNP)
- chronic rhinosinusitis with nasal polyps (CRSwNP)
- chronic spontaneous urticaria
- Chronic spontaneous urticaria (CSU)
- chronic urticaria
- chronicrhinosinusitis
- chronicrhinosinusitiswithnasalpolyps
- chronicurticaria
- chronis rhinosinusitis
- classification
- climate
- climate change
- Clinical aspects
- clinical endotypes
- Clinical immunology
- Clinical immunology Food allergy
- Clinical practice
- clinical relevance
- clinical tolerance
- clinicalimmunology
- Cluster analysis
- cofactors
- Collegen-binding receptor
- common cold
- community
- companion animals and pets
- Company Sponsored Symposia
- compliance
- component resolved diagnosis
- Component resolved diagnosis (CRD)
- component-resolved diagnosis (CRD)
- Conjunctiva
- conjunctivitis
- Consensus
- consensus document
- contact allergen
- contact dermatitis
- Contact urticaria
- containment
- contraindications
- coronavirus
- coronavirusdisease2019
- Cost-effectiveness
- cough
- COVID
- COVID-19
- COVID-19 lockdown
- COVID-19 pandemic
- COVID-19 vaccine
- COVID-19[SupplementaryConcept]
- COVID-19diagnostictesting[SupplementaryConcept]
- COVID-19vaccines
- COVID‐19
- COVID19
- Cow's milk
- Cow's milk allergy
- CRISPR
- criticalillness
- Cross-reactive molecules
- Cross-reactivity
- CRSwNP
- CSU
- Cutaneous manifestation
- cyclosporine
- cytokine
- DAMP
- danger signals
- Danger signs
- dbv technologies
- dbv712
- Deep learning
- delabelling
- Dendritic cells
- Dermatology
- desensitization
- dexamethasone
- DGAKI
- diagnosis
- diet
- dietary management
- Differential diagnosis
- digital anamorphosis
- disease (CRD)
- disease burden
- disease model
- disease transmission
- disinfection by-products
- disruptive IgE antibody
- DNase
- drug allergy
- Drug allergy
- Drug allergy diagnosis
- Drug desensitisation
- Drug hypersensitivity
- drug provocation test
- drug provocation test (dpt)
- Drug provocation tests
- dupilumab
- Dysbiosis
- E-cigarette
- eaaci digital congress 2020
- eaaci hybrid congress 2021
- eaaci hybrid congress 2022
- ECDA
- ecosystem
- Education
- EETosis
- efficacy
- Egg allergy
- EGR-1
- eHealth
- Eldery
- Elimination diet
- Emollient
- Endotype
- Endotypes
- ENT
- ENT (rhinitis
- environment
- Environment and hygiene hypothesis
- Environment and Immunology StandUp Talks
- Environmental exposure chamber (EEC)
- environmentalhealth
- Enzyme-LinkedImmunosorbentAssay[Mesh]
- eosinophil
- eosinophilic fasciitis
- Eosinophilic granulomatosis with polyangiitis (EGPA)
- Eosinophils
- Epicutaneous
- Epicutaneous immunotherapy
- Epidemiology
- epigenetic
- Epithelial barrier
- Epithelial barrier hypothesis
- epithelialcell
- Epithelium
- Epitome
- Epitope specific IgA
- ERS/EAACI
- Esophagitis
- EU
- European parliament
- exacerbations
- Exercise induced anaphylaxis (EIAn)
- Exercise induced asthma
- experimental models
- exposome
- faam-eurobat digital 2020
- fermentedvegetable
- Flow cytometric
- Flow cytometry
- flow-diagram
- flowcytometry
- food
- food additives
- food allergy
- Food allergy
- Food aversion
- food labelling
- Food processing
- food protein induced enterocolitis syndrome (FPIES)
- Food-dependent exercise-induced anaphilaxis (FDEIAn)
- Food-induced anaphylaxis (FIA)
- Fungi
- Gene expression
- Genetics
- Genome-wide association study (GWAS)
- global atlas
- glycans
- grade
- Grant application
- guideline
- Guidelines
- gut microbiome
- Gut microbiota
- health economics
- healthier environment
- Helicobacter pylori
- Helminth infection
- hereditary angioedema
- Hereditary angioedema (HAE)
- Histamine
- Histamine intolerance
- Hologenome
- House dust mite
- House dust mite (HDM)
- house dust mites
- housedust mites
- Human bronchial smooth muscle cells (BMSC)
- hygiene
- Hypereosinophilic syndrome (HES)
- hyperinflammation
- hypersensitivity
- hypersensitivity reactions
- ICD-11
- IgE
- IL-37b
- imaging
- immediate reactions
- Immune amnesia
- Immune deficiencies
- Immune health
- immune phenotype
- immune response
- Immune tolerance
- immunecomplex
- immuneresponse
- Immunization
- immunodeficiencies
- immunoglobulinM
- immunoglobulins
- Immunologic tests
- Immunologic tests
- Immunomodulators
- immunotherapy
- Immunotherapy and tolerance induction
- Immunotherapy clinical
- Immunotherapy vaccines and mechanisms
- Immunotherapy vaccines and mechanisms
- implementationscience
- In vitro assays
- Inborn errors of immunity (IEI)
- Infections
- inferiorturbinate
- Inflammasome
- Inflammation
- Inflammatory bowel disease (IBD)
- inflammatoryendotype
- innate immunity
- Innate immunity
- Innate lymphoid cells and NK cells
- innateimmunity
- Innovation
- Insect Venom Allergy
- insects
- integrated care
- Integrines
- interferon
- Interferons
- Interleukins
- international classification of diseases (ICD)
- international consensus
- intradermal test
- Iodinated contrast media
- italy
- Kawasakisyndrome
- kimchi
- Lactobacillus
- learning methods
- ligelizumab
- lipid transfer protein
- Lipid transfer protein (LTP)
- Local allergic rhinitis
- Lolium Perenne
- long-term immunity
- Long-term prophylaxis
- LTP
- LTRA
- Lung diseases other than asthma and COPD
- lung function
- lung function test
- Lung function tests
- lymphocyte transformation test (LTT)
- Lymphocytes
- Machine learning
- Macrophages
- Malignant
- management
- marketing authorization
- Masitinib
- Mast cells
- Mast cells
- Mast cells Dermatology
- mastocytosis
- Mastocytosis scale (QLMS)
- mechanisms
- memory B cells
- mental health
- Mepolizumab
- Metabolite
- metabolites
- Metabolomics
- Metalloproteinase 9
- mHealth
- Microbial Disease
- Microbiome
- microbiota
- MicroCrystalline
- microRNA
- MicroRNA (miRNA)
- Mobile health (mHealth)
- Moisturisers
- molecular allergology
- Molecular phenotypes
- molecularinteractionassay
- Molecules
- monoclonal Abs
- monocytes
- MOOC
- MRGPRX2
- mRNA
- mRNA vaccines
- multi-disciplinary management
- Multiple myeloma
- multisystem allergy
- multisysteminflammatorysyndrome
- mumps‐measles‐rubella
- myeloperoxidase
- nasal allergen challenge
- nasal polyposis
- nasal polyps…)
- neonates
- Neuroimmunology
- Neuronal control
- Neutralizing[Mesh]
- neutralizingantibody
- neutrophil extracellular traps (NETs)
- neutrophilextra-cellulartraps(NETs)
- neutrophils
- New challenges
- newborns
- Next generation
- NLR
- non-immediate reactions
- non-specialist care
- non-steroidal anti-inflammatory drugs (NSAID)
- non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
- noninvasive diagnosis
- Novartis
- Novel mechanisms
- NSAID
- nsaid-exacerbated respiratoy disease (NERD)
- nutrients
- Nutrition
- Obesity
- Occupational asthma
- occupational exposure
- Ocular allergy
- older adults
- Olfactory disturbance
- Olink
- omalizumab
- omic
- One Health
- OneHealth
- Oral allergy syndrome (OAS)
- oral challenge
- oral corticosteroids
- Oral immunotherapy
- outbreak
- Outcome measures
- PAAM Digital 2021
- Paediatrics
- PAMP
- Panallergen
- pandemic
- Particular matter (PM)
- Patch test
- Patch tests
- patient reported outcome
- patient-centered care
- peak expiratory flow
- peak expiratory flow (PEF)
- Peanut
- Peanut allergy
- pediatric
- pediatric aspects
- pediatric atopic dermatitis
- pediatrics
- Peptide immunotherapy
- perioperative allergy
- Personalized medicine
- pharmacoeconomics
- Pharmacology and pharmacogenomics
- Phase-3 study
- Phenotype
- phenotypes
- Pine nut allergy
- PIPEline
- Placebo effect
- Plane tree
- Platanus hybrida
- Pneumology
- pneumonia
- Polish Allergology Society
- Pollen
- Pollen food syndrome
- Pollen forecast
- Pollen monitoring
- pollutants
- pollution
- polyethilen glycol
- polyethylene glycol
- PRACTALL
- prebiotics
- Precision medicine
- precision medicine
- prediction
- Prediction model
- Pregnancy
- Prematurity
- preschool
- Prevention
- primary care
- primary immunodeficiency
- Probiotic
- probiotics
- proctocolitis
- proresolvinglipids
- protection
- protectiveantibodies
- protein contact dermatitis
- proteomics
- Proteotomics
- Proton pump inhibitor
- pruritus
- Psoriasis
- psychological effects
- psychology
- pulmonary rehabilitation
- Quality-of-life
- qualitycriteria
- Questionnaire
- race
- Ragweed
- randomized controlled trial
- Rapid drug desensitization
- Real life
- real-life
- real-world evidence
- Recipe
- recreational exposure
- RED-ZONE
- regulation
- Regulatory aspects
- regulatory authorities
- RELEVANT
- Remodelling
- respiratory allergies
- respiratory allergy
- Respiratory infections
- Rhinitis
- Rhinitis Monitoring
- rhinoconjuctivitis
- Rhinoconjunctivitis
- Rhinosinusitis (RS)
- Rhinovirus
- risk assessment
- risk factors
- riskfactors
- RLR
- safety
- SAM 2021
- SANI
- Sanofi Regeneron
- SARC-CoV-2
- SARS-CoV
- SARS-CoV-2
- SARS-CoV-2 vaccine
- SARS‐CoV‐2
- Satellite Symposia
- SCARs (severe cutaneous adverse drug reactions)
- scientific career
- SCIT
- self-care
- self‐management
- sensitization
- sensitization profile
- Sepsis
- sequencing (NGS)
- severe allergic reactions
- severe asthma
- Severe cutaneous adverse drug reactions (SCARs)
- severe cutaneous adverse drug reactons
- severe type 2 asthma
- SevereAcuteRespiratorySyndromeCoronavirus2[SupplementaryConcept]
- severeallergicreactions
- severity
- sIgG
- Single nucleotide polymorphisms (SNPs)
- sinus
- sinusitis
- Skin
- skin allergy
- Skin barrier
- skin diseases
- skin test
- Skincare
- sleep pattern
- SLIT
- smell
- SoMe
- Spirometry
- Sports
- sputuminduction
- Stallergenes Greer
- standardization
- StandUp Talks
- Stevens-Johnson syndrome (SJS)
- Stratification
- subcutaneous immunotherapy
- Sublingual
- sublingual immunotherapy
- sulforaphane
- Sulfur mustard Stem cells
- supplementation
- survey
- Symptom scale
- Symptom score
- systematic review
- Systemic mastocytosis (SM)
- T cells
- T cells
- t2 diseases
- Tcells
- tele-health
- teleHealth
- telemedicine
- Terriers
- Tezepelumab
- Th2 cell
- Th2 sensitization
- threshold dose
- Thunderstorm asthma
- TLR
- TMPRSS2
- tolerance
- Trained immunity
- trainedimmunity
- Transcriptome
- Transcriptomics
- transition
- Transition process
- translationalresearch
- transmissionofdisease
- treatment
- tree nut allergy
- Tree-nut allergy
- Trichinella spiralis
- Tryptase
- type 2 inflammation
- UCARE
- umfrage
- unmet needs
- Urban green spaces
- Urban particulate matter
- Urticaria
- urticaria diagnosis
- urticaria treatment
- urticarial vasculitis
- Vaccination
- vaccine
- Vaccines
- Vaping
- Venom and insect allergy
- venom immunotherapy
- Viral reactivation
- Virtual care
- Virus
- WAO
- wheezing
- white paper
- WS 2023 Davos
- Xlinkedagammaglobulinemia
- yellow fever
- young
- young adults
Author
- Achten, R.
- Adamiec, A.
- Adcock, I.
- Agache, I.
- Aggelides, X.
- Akdis, C.A.
- Akdis, M.
- Akin, C.
- Allegri, P.
- Alvarez-Cuesta, E
- Alvarez-Perea, A.
- Alvaro-Lozano, M.
- Alviani, C.
- Ambrożej, D.
- Angier, E.
- Anna Pastorello, E.
- Annesi-Maesano, I.
- Antje Faber, M.
- Antolin-Amerigo, D.
- Antunes, C.
- Apoil, P.
- Arasi, S.
- Arcolaci, A.
- Arkhipova, S.
- Arnold, A.
- Arrais, M.
- Asero, R.
- Atanaskovic-Markovic, M.
- Ayane, A.
- Bacharier, L.
- Bachert, C.
- Baerenfaller, K.
- Ballmer-Weber, B.K.
- Barbaud, A.
- Barber, D.
- Bartel, S
- Bartra, J.
- Baumann, R
- Bavbek, S.
- Bazan-Socha, S.
- Beck, E.
- Beck, L.
- Bedbrook, A.
- Bégin, P.
- Beken, B.
- Benito Villalvilla, C.
- Bergmann, C.
- Bernard, A.
- Bernstein, D.
- Bernstein, J.
- Besednjak-Kocijancic, L.
- Beyer, K.
- Bianchini, R.
- Biedermann, T.
- Bikov, A.
- Bindslev-Jensen, C.
- Birrell, F.
- Bisyuk, y.
- Bjermer, L.
- Blanca-Lopez, N.
- Blasi, F.
- Blumchen, K.
- Blümchen, K.
- Boccabella, C.
- Boguniewciz, M.
- Bohle, B.
- Böhm, I.
- Bonini, M.
- Bosnic-Anticevich, S.
- Bossios, A.
- Bousquet, J.
- Boyce, J.
- Boyle, R.
- Bozek, A
- Bozkurt, B.
- Branicka, O.
- Braun, A.
- Braunstahl, G.
- Brignole-Baudouin, F.
- Brockow, K.
- Brough, H.A.
- Brucker, H.
- Brusselle, G.
- Burks, W.
- Busse, W.
- Caballero, M.
- Cabanillas, B.
- Cabrera, M.
- Calado, R.
- Calder, V.
- Calderon, M
- Calvão, J.
- Camargo Lopes de Oliveira, L.
- Campbell, D.
- Canonica, G.W.
- Cardona, V.
- Carter, M.
- Caruso, C.
- Castells, M.
- Caubet, J-C.
- Caubet, J.-C.
- Cavaleiro Rufo, J.
- Cecchi, L.
- Chaker, A.
- Chan, E.
- Chawes, B.
- Chehade, M.
- Chivato, T.
- Cho, Y.
- Chung, K.
- Cianferoni, A.
- Clark, A.
- Clark, E.
- Clini, E.
- Cogo, A.
- Cojanu, C.
- Comberiati, P.
- Constantinides, M.
- Corbett, M.
- Cornejo-Garcia, JA
- Correia-de-Sousa, J.
- Corren, J.
- Corrigan, C.
- Coutinho, C.
- Couto, M.
- Craig, T.
- Cullinan, P.
- Cunha, I.
- Custovic, A.
- D'Amato, G.
- Davidescu, L.
- Dávila, I.
- de Blay, F.
- de Jong, N.
- de las Vecillas, L.
- de Silva, D.
- de Swart, R.
- de Waard-van der Spek, F.
- del Giacco, S.
- Delgado, L.
- Demoly, P
- Descamps, V.
- Deschildre, A.
- Deshpande, D.
- di Bona, D.
- Diamant, Z.
- Diaz Perales, A.
- Diwakar, L.
- Doğru, M.
- Domínguez Andrés, J.
- Doña, I.
- Dramburg, S.
- Drijver-Messelink, MT
- du Toit, G.
- Duca, B.
- Dunn Galvin, A.
- DunnGalvin, A.
- Durham, S.
- Eberlein, B.
- Ebisawa, M.
- Ebo, D.G.
- Eggel, A.
- Eguiluz-Gracia, I.
- Eguiluz, I.
- Eigenmann, P.
- Eiwegger, T.
- Elenius, V
- Eljaszewicz, A.
- Emeryk, A.
- Emson, C.
- Erkekol, F.
- Eyerich, K.
- Faber, M.A.
- Fakhimahmadi, A.
- Farkas, H.
- Fauquert, J.
- Favaro, A.
- Feketea, G.
- Feleszko, W.
- Fernández Santamaría, R.
- Fernández-Rivas, M.
- Ferrando anaut, P.
- Fieten, KB
- Figueras Alsius, M
- Fiocchi, A.
- Firinu, D.
- Flokstra – de Blok, BMJ
- Flood, B.
- Florsheim, E.
- Fokkens, W.
- Fonseca, J.
- Forastiere, F.
- Fu, W.
- Gainsborough, F.
- Galvan Blasco, P.
- Gamez, C.
- Garriga-Baraut, T.
- Garvey, LH
- Gaudenzio, N.
- Gelincik, A.
- Geng, B.
- Gennery, A.
- Genuneit, J.
- Gern, J.
- Gerth van Wijk, R.
- Gevaert, P.
- Gherasim, A.
- Giménez-Arnau, A.
- Giovannini, M.
- Golding, M.
- Gomes, E.R.
- Gomes, J.
- Gomez, F.
- Goncalo, M.
- Gonçalo, M.
- González Díaz, S
- González germán, M.
- Goodman, R.
- Goossens, A.
- Gore, C.
- Gowland, M.
- Grattan, C.
- Greenhawt, M.
- Gunawardana, N.
- Gupta, R.
- Gutermuth, J.
- Guttman Yassky, E.
- Guttman, E.
- Halken, S.
- Hamilton, J.
- Hartmann, K.
- Heffler, E.
- Heldner, A.
- Hellings P.
- Hermuth-Kleinschmidt, K.
- Herth, F.
- Hilger, C.
- Hirahara, K.
- Hoffmann-Sommergruber, K.
- Hoffmann, H-J.
- Holgate, S.
- Holmdahl, I.
- Horvath, I.
- Howarth, P.
- Hox, V.
- Huang, Y
- Humbert, M.
- In't Veen, H.
- Izquierdo, E.
- Izuhara, K.
- Jackson, D.
- Jacobsen, L.
- Jakob, T.
- Janda, J.
- Janson, C.
- Jeebhay, M.
- Jeimy, S.
- Jensen-Jarolim, E.
- Jensen, B.
- Jiménez-Saiz, R.
- Johnston, S.
- Jones, A.
- Juskiene, I.
- Jutel, M.
- K Chu, D.
- Kalayci, O.
- Kang, M.
- Kappen, J.
- Kase Tanno, L.
- Kelleher, M.
- Khaitov, M.
- Khaleva, E.
- Kheradmand, F.
- Kiani-alikhan, S.
- Kidon, M.
- Kılıç, A.
- Kleine-Tebbe, J.
- Kleuskens, M.
- Klimek, L.
- Knibb, R.
- Knol, E.
- Kocatürk, E.
- Köhler, V.
- Konstantinopoulos, A.P.
- Korath, ADJ
- Korn, S.
- Kortekaas Krohn, I.
- Kosowska, A.
- Kothalawala, D.
- Kozlik, P.
- Kucharczyk, A.
- Kuna, P.
- Kündig, T.
- Kupczyk, M.
- Kuyucu, S.
- Kuziemski, K.
- Lack, G.
- Lang, D.
- Larché, M.
- Larenas-linnemann, D.
- Lau, S.
- Lauerma, A.
- Lee, Y.
- Leonardi, A.
- Lopata, A.
- Luengo, O.
- Macchia, L.
- Madrigal-Burgaleta, R.
- Magerl, M.
- Mahler, V.
- Maleki, S.
- Malmberg, PL.
- Marcoux, D.
- Marrs, T.
- Marsella, R.
- Martins, C.
- Maspero, J.
- Mastalerz, L.
- Mathioudakis, A.
- Matricardi, P
- Matucci, A.
- Maurer, M.
- Mayerhofer, H.
- Mayorga, C.
- McSorley, H.
- Melén, E.
- Meyer, R.
- Mikkelsen, A.
- Mockenhaupt, M.
- Moloudizargari, M.
- Montimer, K.
- Mori, F.
- Mortz, C.G.
- Mösges, R.
- Moya, B.
- Mueller, Ralf S.
- Mukherjee, M.
- Mullol, J.
- Muraro, A
- Myszkowska, D.
- Nadeau, K.C.
- Nasser, S.
- Novak, N.
- Nwaru, B.
- O'B Hourihane, J.
- O’Mahony, L.
- Ogese, M.
- Ogg, G.
- Ogneva, D.
- Ollert, M.
- Ong, P.Y.
- Pagani, M.
- Pali-Schöll, I
- Palomares, O.
- Paoletti, G.
- Papadopoulos, N.
- Paplinska-Goryca, M.
- Park, H.
- Pascal, M.
- Pasmans, S.
- Pastorello, E.A.
- Pavlova, K.
- Pavord, I.
- Peden, D.
- Pepys, J.
- Pérez de Llano, L.
- Perkin, M.
- Permaul, P.
- Peters, A.
- Pfaar, O.
- Pietikäinen, S.
- Pinnock, H.
- Pite, H.
- Pitsios, C.
- Poli, A.
- Popescu, F.
- Portelli, M.
- Prunicki, M.
- Qazi, K.
- Quirce, S.
- Rabe, K. F.
- Rabin, R.L.
- Radzikowska, U.
- Reese, I.
- Reginald, K.
- Renz, H.
- Reynolds, N.
- Ricci, C.
- Riggioni, C.
- Ring, J.
- Roberts, G
- Roberts, G.
- Rodrigo-Muñoz, J.
- Rodrigues cernadas, J.
- Rondon, C.
- Rossi, A.
- Rostaher, A.
- Roth-Walter, F.
- Rothenberg, M.
- Rovati, GE
- Rubin, E.
- Rudenko, M.
- Rukhadze, M.
- Rustemeyer, T.
- Ryan, D.
- Sabato, V.
- Sabouraud, D.
- Sadeghi, S.
- Salapatek, A.
- Sampson, H.
- Sanchez-Garcia, S.
- Sandoval-Ruballos, M.
- Santos, A.
- Sastre, J.
- Savic, S.
- Scadding, G
- Scala, E.
- Scheib, N.
- Scherrer, K.
- Schmid, B.
- Schuijs, M.
- Schwarze, J.
- Sediva, A.
- Sekerel, B.
- Semernik, O.
- Serrano, C.
- Shamji, M.H.
- Skypala, I.J.
- Smolinska, S.
- Sokolowska, M.
- Solinski, M.
- Song, K.
- Sorensen, K.
- Soyer, O.
- Spanevello, A.
- Spergel, J.
- Spolak-Bobryk, N.
- Stevens, W.
- Straumann, A.
- Sturm, G.
- Sublett, J.
- Suojalehto, H.
- Suprun, M.
- Swanson, W.S.
- Swoboda, I.
- Szajewska, H.
- Szefler, S.
- Szymanski, L.
- Tan, B.
- Tanno, L.
- Tham, E.
- Thibaudon, M.
- Thien, F.
- Thirumala Krishna, M.
- Till, S.J.
- Timmermans, F.
- Togias, A.
- Tomazic, P.
- Tonia, T.
- Torrado español, I.
- Torres, M.J.
- Torun, E.
- Traidl-Hoffmann, C.
- Tramper-Stranders, G.
- Trautmann, A.
- Troy, N.
- Tsabouri, S.
- Tsilochristou, O.
- Ueki, S.
- Untersmayr, E.
- Vaia, E.
- Van Bilsen, J.
- Van Cuilenborg, V.
- van den Berge, M.
- Van Dijk, Y.
- van Neerven, R.
- van Ree, R.
- Van Weissenbruch, R.
- Vandenplas, Y.
- Vassilopoulou, E.
- Vazquez-Ortiz, M.
- Vega Castro, A.
- Venter, C.
- Verhasselt, V.
- Vieths, S.
- Villaseñor solis, A.
- Vlieg- Boerstra, B.
- Vogelberg, C.
- von Mutius, E.
- Vultaggio, A.
- Walter, J.
- Wang, J.
- Wardzynska, A.
- Warner, A.
- Wechsler, M.
- Weidner, J.
- Weinberger, B.
- Werfel, T.
- Wiehn, E.
- Williams, S.
- Wong, C.
- Worm, M.
- Worm, M.
- Yuste-Montalvo, A.
- Zednik, K.
- Zhang, L.
- Zieglmayer, P.
- Zissler, UM
- Zuberbier, T.

Presentation 06 Dec 2022

We are what we eat – importance of food to health, moving past simple calories
- Venter, C.
Read about this Presentation
Presentation 06 Dec 2022

Vaccines- Is this the tool to end the pandemic?
- Rubin, E.
Read about this Presentation
Presentation 06 Dec 2022

Vaccines for older adults: benefits and limitations
- Weinberger, B.
Read about this Presentation
Presentation 06 Dec 2022

Using BAT for differentiation between sensitization and allergy to alpha-gal
- Eberlein, B.
Read about this Presentation
Presentation 06 Dec 2022

Updates in [severe] asthma in adults
- Bossios, A.
Read about this Presentation
Presentation 06 Dec 2022

Update of the WAO anaphylaxis guidance
- Cardona, V.
Read about this Presentation
Presentation 06 Dec 2022

Understanding immunological mechanisms that confer a higher risk of allergy
- Jiménez-Saiz, R.
Read about this Presentation
Presentation 06 Dec 2022

Tree nut allergy: path from national to global data
- Sekerel, B.
Read about this Presentation
Presentation 06 Dec 2022

Treating allergic patients during the COVID-19 pandemic
- Tham, E.
Read about this Presentation
Presentation 06 Dec 2022

Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy
- Eljaszewicz, A.
Read about this Presentation
Presentation 06 Dec 2022

Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
- Pite, H.
Read about this Presentation
Presentation 06 Dec 2022

The underlying immunology of pruritus
- Gaudenzio, N.
Read about this Presentation
Presentation 06 Dec 2022

The trajectory of immune development in early life and its association with clinical allergic disease outcomes
- Gamez, C.
Read about this Presentation
Presentation 06 Dec 2022

The engineering-medicine interface
- Agache, I.
Read about this Presentation
Presentation 06 Dec 2022

The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
- Corren, J.
Read about this Presentation
Presentation 06 Dec 2022

The dilemma of food allergy additives
- Vaia, E.
Read about this Presentation
Presentation 06 Dec 2022

The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer
- Jensen-Jarolim, E.
Read about this Presentation
Presentation 06 Dec 2022

The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
- Pavlova, K.
Read about this Presentation
Presentation 06 Dec 2022

The brain, nose, immune axis
- Tomazic, P.
Read about this Presentation
Presentation 06 Dec 2022

Telemedicine and Tele-health
- Smolinska, S.
Read about this Presentation
Presentation 06 Dec 2022

Tackling anaphylaxis
- Zuberbier, T.
Read about this Presentation
Presentation 06 Dec 2022

Should blood eosinophils tresholds guide patient selection for anti-IL5 biologicals? (Pro&Con Session: Pro)
- Pavord, I.
Read about this Presentation
Presentation 06 Dec 2022

Severe cutaneous allergic reactions: searching for the culprit drug
- Serrano, C.
Read about this Presentation
Presentation 06 Dec 2022

Role of antigen-presenting cells in tolerance and allergy
- Benito Villalvilla, C.
Read about this Presentation
Presentation 06 Dec 2022

Risk factors for conjunctivitis in atopic dermatitis patients treated with dupilumab: results from the bioday registry
- Achten, R.
Read about this Presentation
Presentation 06 Dec 2022

Recognizing immediate reactions in contact dermatitis
- Lauerma, A.
Read about this Presentation
Presentation 06 Dec 2022

Real-life evidence of the burden of chronic rhinosinusitis (CRS)
- Heffler, E.
Read about this Presentation
Presentation 06 Dec 2022

Psychological support to peanut allergic children and their families
- Dunn Galvin, A.
Read about this Presentation
Presentation 06 Dec 2022

Proteomic and biological analysis of human in vitro vascular smooth muscle cell system in response to anaphylaxis
- Yuste-Montalvo, A.
Read about this Presentation
Presentation 06 Dec 2022

Primary care in CRDs during COVID
- Williams, S.
Read about this Presentation
Presentation 06 Dec 2022

Prevention and therapy in primary immunodeficiencies: Vaccination
- Gennery, A.
Read about this Presentation
Presentation 06 Dec 2022

Predicting adverse reactions to biologicals
- Torres, M.J.
Read about this Presentation
Presentation 06 Dec 2022

Practical approach of diagnosis and management of not IgE mediated food allergies
- Eigenmann, P.
Read about this Presentation
Presentation 06 Dec 2022

Plans of GARD in terms of surveillance after COVID
- Chivato, T.
Read about this Presentation
Presentation 06 Dec 2022

Phenotypes and endotypes of occupational allergy
- Sastre, J.
Read about this Presentation
Presentation 06 Dec 2022

Personalized nutrition approach towards better QOL in Food Allergy
- Venter, C.
Read about this Presentation
Presentation 06 Dec 2022

Pediatric Covid-19 highlights published in PAI in 2020
- Eigenmann, P.
Read about this Presentation
Presentation 06 Dec 2022

Pathogenic Th cell population disease induction model: – From the recruitment of eosinophils to the induction of fibrosis
- Hirahara, K.
Read about this Presentation
Presentation 06 Dec 2022

Oral food challenges thresholds for clinical reactions
- Santos, A.
Read about this Presentation
Presentation 06 Dec 2022

Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
- Cho, Y.
Read about this Presentation
Presentation 06 Dec 2022

ÖGAI: Covid as best practice model to combine immunology and allergy
- Jensen-Jarolim, E.
Read about this Presentation
Presentation 06 Dec 2022

Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
- Mastalerz, L.
Read about this Presentation
Presentation 06 Dec 2022

New insights in urticaria mechanisms
- Knol, E.
Read about this Presentation
Presentation 06 Dec 2022

New and clinically relevant contact allergens
- Gonçalo, M.
Read about this Presentation
Presentation 06 Dec 2022

Nasal allergen challenge
- Rondon, C.
Read about this Presentation
Presentation 06 Dec 2022

Molecular and structural considerations for aerosolization of food allergens
- Lopata, A.
Read about this Presentation
Presentation 06 Dec 2022

Microbiota in immune-based therapies
- von Mutius, E.
Read about this Presentation
06 Dec 2022

Metabolic changes in the prediction of severe anaphylactic reactions
- Villaseñor solis, A.
Read about this
Presentation 06 Dec 2022

Mental health during the COVID-19 pandemic: how to cope with job stress and build resilience
- Dunn Galvin, A.
Read about this Presentation
Presentation 06 Dec 2022

May contain traces… management in children with food allergies
- Eigenmann, P.
Read about this Presentation
Presentation 06 Dec 2022

MAIT cells are imprinted by the microbiota in early life and promote tissue repair
- Constantinides, M.
Read about this Presentation
Presentation 06 Dec 2022

Living with food allergy
- Knibb, R.
Read about this Presentation
Presentation 06 Dec 2022

Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
- Togias, A.
Read about this Presentation
Presentation 06 Dec 2022

Introduction – why bacterial lysates in the treatment of allergic diseases? / Wprowadzenie – dlaczego lizaty bakteryjne w terapii schorzen alergicznych ?
- Feleszko, W.
Read about this Presentation
Presentation 06 Dec 2022

Inhibiting Type 2 inflammation in atopic dermatitis with dupilumab modulates COVID-19 responses
- Guttman Yassky, E.
Read about this Presentation
Presentation 06 Dec 2022

Implementation of telehealth in asthma management: trials and tribulations
- Szefler, S.
Read about this Presentation
Presentation 06 Dec 2022

Immune regulation in specific B cells in food allergy, tolerance and outgrowing children
- Akdis, M.
Read about this Presentation
Presentation 06 Dec 2022

Hypersensitivity to antiepileptic drugs
- Atanaskovic-Markovic, M.
Read about this Presentation
Presentation 06 Dec 2022

How to select and follow a biological for asthma and CRSwNP
- Pérez de Llano, L.
Read about this Presentation
Presentation 06 Dec 2022

How to improve outcomes
- Roberts, G.
Read about this Presentation
Presentation 06 Dec 2022

How to improve compliance of allergen immunotherapy in the clinic?
- Durham, S.
Read about this Presentation
Presentation 06 Dec 2022

How to evaluate lung function? Hands-on plus lecture
- Kupczyk, M.
Read about this Presentation
Presentation 06 Dec 2022

How does Type 2 mucosal inflammation influence susceptibility to SARS-CoV-2?
- Jackson, D.
Read about this Presentation
Presentation 06 Dec 2022

Global impact of the COVID-19 on the environment
- Chung, K.
Read about this Presentation
Presentation 06 Dec 2022

Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
- Skypala, I.J.
Read about this Presentation
Presentation 06 Dec 2022

Food allergy: new allergens on the block
- Camargo Lopes de Oliveira, L.
Read about this Presentation
Presentation 06 Dec 2022

Food allergy – the beginners guide
- Alvarez-Perea, A.
Read about this Presentation
Presentation 06 Dec 2022

Flare-up phenomenon of Sars-CoV2 vaccine secondary to epicutaneous test with polyethylene glycol
- Torrado español, I.
Read about this Presentation
Presentation 06 Dec 2022

Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
- Eguiluz-Gracia, I.
Read about this Presentation
Presentation 06 Dec 2022

Eosinophilic fasciitis, an unusual presentation
- Ferrando anaut, P.
Read about this Presentation
Presentation 06 Dec 2022

Eosinophil ETosis, a cytolytic degranulation and diseases
- Ueki, S.
Read about this Presentation
Presentation 06 Dec 2022

Entre US y Europa. La Experiencia de la Inmunoterapia en Mexico
- Larenas-linnemann, D.
Read about this Presentation
Presentation 06 Dec 2022

Endotype-driven treatment in chronic rhinosinusitis
- Peters, A.
Read about this Presentation
Presentation 06 Dec 2022

EAACI Guidelines on environmental health
- Akdis, C.A.
Read about this Presentation
Presentation 06 Dec 2022

Dysregulated regulation of skin structure and barrier function by insufficient IL-37 in allergic inflammation of atopic dermatitis
- Wong, C.
Read about this Presentation
Presentation 06 Dec 2022

Durable reduction in hereditary angioedema (HAE) attack rates with berotralstat over 24 months: results from the phase 3 apeX-2 study
- Kiani-alikhan, S.
Read about this Presentation
Presentation 05 Dec 2022

Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
- Wechsler, M.
Read about this Presentation
Presentation 05 Dec 2022

Difficult to control asthma in children
- Szefler, S.
Read about this Presentation
Presentation 05 Dec 2022

Difficult to control asthma in adults
- Busse, W.
Read about this Presentation
Presentation 05 Dec 2022

Diagnosis of insect venom allergy: back to basics
- Sturm, G.
Read about this Presentation
Presentation 05 Dec 2022

Desensitization in chemotherapy and biologics
- Rodrigues cernadas, J.
Read about this Presentation
Presentation 05 Dec 2022

Delabelling adults
- Torres, M.J.
Read about this Presentation
Presentation 05 Dec 2022

Current and future perspectives
- Mukherjee, M.
Read about this Presentation
Presentation 05 Dec 2022

COVID-19 Vaccination: Separating facts from fiction for your patients
- Moya, B.
Read about this Presentation
Presentation 05 Dec 2022

Covid-19 in “Allergy” journal
- Akdis, C.A.
Read about this Presentation
Presentation 05 Dec 2022

COVID-19 and virus-induced asthma in children: Asian vs western perspectives
- Wang, J.
Read about this Presentation
Presentation 05 Dec 2022

Contraindications to venom immunotherapy and risk factors for adverse events: any left?
- Sturm, G.
Read about this Presentation
Presentation 05 Dec 2022

Component Resolved Diagnosis and pollen Immunotherapy indication
- Barber, D.
Read about this Presentation
Presentation 05 Dec 2022

Can we prevent the development of food allergy?
- Santos, A.
Read about this Presentation
Presentation 05 Dec 2022

Bronchial allergen challenge in the clinic
- Eguiluz-Gracia, I.
Read about this Presentation
Presentation 05 Dec 2022

Bronchial allergen challenge in research
- Gherasim, A.
Read about this Presentation
Presentation 05 Dec 2022

Biomarkers and predictors of responses to biologicals in atopic dermatitis
- Guttman Yassky, E.
Read about this Presentation
Presentation 05 Dec 2022

Beyond first line therapies for recalcitrant allergic diseases: Asthma
- Corbett, M.
Read about this Presentation
Presentation 05 Dec 2022

BAT in clinical practice. Is it possible?
- Knol, E.
Read about this Presentation
Presentation 05 Dec 2022

Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
- Emeryk, A.
Read about this Presentation
Presentation 05 Dec 2022

Asthma management during the COVID-19 pandemics
- del Giacco, S.
Read about this Presentation
Presentation 05 Dec 2022

Asthma endotypes as risk factors for severe COVID-19 manifestations
- Johnston, S.
Read about this Presentation
Presentation 05 Dec 2022

Asma e alergia em pandemia
- Delgado, L.
Read about this Presentation
Presentation 05 Dec 2022

Asma e alergia em Angola
- Arrais, M.

EAACI 2021

What are you looking for?

We are what we eat – importance of food to health, moving past simple calories

Vaccines- Is this the tool to end the pandemic?

Vaccines for older adults: benefits and limitations

Using BAT for differentiation between sensitization and allergy to alpha-gal

Updates in [severe] asthma in adults

Update of the WAO anaphylaxis guidance

Understanding immunological mechanisms that confer a higher risk of allergy

Tree nut allergy: path from national to global data

Treating allergic patients during the COVID-19 pandemic

Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy

Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?

The underlying immunology of pruritus

The trajectory of immune development in early life and its association with clinical allergic disease outcomes

The engineering-medicine interface

The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study

The dilemma of food allergy additives

The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer

The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps

The brain, nose, immune axis

Telemedicine and Tele-health

Tackling anaphylaxis

Should blood eosinophils tresholds guide patient selection for anti-IL5 biologicals? (Pro&Con Session: Pro)

Severe cutaneous allergic reactions: searching for the culprit drug

Role of antigen-presenting cells in tolerance and allergy

Risk factors for conjunctivitis in atopic dermatitis patients treated with dupilumab: results from the bioday registry

Recognizing immediate reactions in contact dermatitis

Real-life evidence of the burden of chronic rhinosinusitis (CRS)

Psychological support to peanut allergic children and their families

Proteomic and biological analysis of human in vitro vascular smooth muscle cell system in response to anaphylaxis

Primary care in CRDs during COVID

Prevention and therapy in primary immunodeficiencies: Vaccination

Predicting adverse reactions to biologicals

Practical approach of diagnosis and management of not IgE mediated food allergies

Plans of GARD in terms of surveillance after COVID

Phenotypes and endotypes of occupational allergy

Personalized nutrition approach towards better QOL in Food Allergy

Pediatric Covid-19 highlights published in PAI in 2020

Pathogenic Th cell population disease induction model: – From the recruitment of eosinophils to the induction of fibrosis

Oral food challenges thresholds for clinical reactions

Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice

ÖGAI: Covid as best practice model to combine immunology and allergy

Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)

New insights in urticaria mechanisms

New and clinically relevant contact allergens

Nasal allergen challenge

Molecular and structural considerations for aerosolization of food allergens

Microbiota in immune-based therapies

Metabolic changes in the prediction of severe anaphylactic reactions

Mental health during the COVID-19 pandemic: how to cope with job stress and build resilience

May contain traces… management in children with food allergies

MAIT cells are imprinted by the microbiota in early life and promote tissue repair

Living with food allergy

Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective

Introduction – why bacterial lysates in the treatment of allergic diseases? / Wprowadzenie – dlaczego lizaty bakteryjne w terapii schorzen alergicznych ?

Inhibiting Type 2 inflammation in atopic dermatitis with dupilumab modulates COVID-19 responses

Implementation of telehealth in asthma management: trials and tribulations

Immune regulation in specific B cells in food allergy, tolerance and outgrowing children

Hypersensitivity to antiepileptic drugs

How to select and follow a biological for asthma and CRSwNP

How to improve outcomes

How to improve compliance of allergen immunotherapy in the clinic?

How to evaluate lung function? Hands-on plus lecture

How does Type 2 mucosal inflammation influence susceptibility to SARS-CoV-2?

Global impact of the COVID-19 on the environment

Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy

Food allergy: new allergens on the block

Food allergy – the beginners guide

Flare-up phenomenon of Sars-CoV2 vaccine secondary to epicutaneous test with polyethylene glycol

Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies

Eosinophilic fasciitis, an unusual presentation

Eosinophil ETosis, a cytolytic degranulation and diseases

Entre US y Europa. La Experiencia de la Inmunoterapia en Mexico

Endotype-driven treatment in chronic rhinosinusitis

EAACI Guidelines on environmental health

Dysregulated regulation of skin structure and barrier function by insufficient IL-37 in allergic inflammation of atopic dermatitis

Durable reduction in hereditary angioedema (HAE) attack rates with berotralstat over 24 months: results from the phase 3 apeX-2 study

Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil

Difficult to control asthma in children